MWM
TMO icon

Moran Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Moran Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-651
Closed -$377K – 558
2025
Q4 		$377K Sell
651
-230
-26% -$130K 0.01% 423
2025
Q3 		$427K Sell
881
-51
-5% -$23.7K 0.01% 424
2025
Q2 		$378K Sell
932
-92
-9% -$38.5K 0.01% 439
2025
Q1 		$510K Sell
1,024
-65
-6% -$35.2K 0.02% 384
2024
Q4 		$567K Buy
1,089
+26
+2% +$14.3K 0.02% 364
2024
Q3 		$658K Buy
1,063
+9
+0.9% +$5.33K 0.02% 349
2024
Q2 		$583K Buy
1,054
+380
+56% +$218K 0.02% 337
2024
Q1 		$392K Buy
674
+249
+59% +$140K 0.01% 348
2023
Q4 		$226K Buy
+425
New +$206K 0.01% 393
2023
Q3 		– Sell
-7,687
Closed -$4.01M – 427
2023
Q2 		$4.01M Sell
7,687
-1,645
-18% -$888K 0.15% 177
2023
Q1 		$5.38M Sell
9,332
-570
-6% -$321K 0.2% 150
2022
Q4 		$5.45M Buy
+9,902
New +$5.25M 0.21% 139

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Moran Wealth Management's TMO Position: Q1 2026 in Review

Moran Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 651 shares — an estimated $377K sold.

Moran Wealth Management first reported a position in TMO in Q4 2022 and held it in 12 quarters. The position peaked at $5.45M in Q4 2022. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Moran Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Moran Wealth Management sold 651 Thermo Fisher Scientific shares in Q1 2026, an estimated $377K.
  • Moran Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 12 quarters.
  • Moran Wealth Management's Thermo Fisher Scientific position peaked at $5.45M in Q4 2022.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Moran Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.